Amgen ends trials of stomach-cancer therapy

November 24, 2014 3:16 PM

5 0

Amgen ends trials of stomach-cancer therapy

Amgen Inc. said it ended clinical studies of a treatment for advanced stomach cancer based on safety concerns.

The biopharmaceutical company said an independent data-monitoring committee found an increase in the number of deaths in patients using a combination of the experimental drug--rilotumumab--and chemotherapy, compared with the arm that received only chemotherapy treatment.

Also read: National Cancer Institute Says Researchers Didn’t Quickly Tell FDA After Two Deaths in a Lymphoma Study

Read more

To category page